Summit Place Financial Advisors’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-16,000
Closed -$80K 102
2022
Q2
$80K Sell
16,000
-200
-1% -$1.05K 0.07% 101
2022
Q1
$115K Buy
16,200
+425
+3% +$3.52K 0.08% 105
2021
Q4
$287K Buy
15,775
+1,350
+9% +$29.1K 0.2% 92
2021
Q3
$282K Buy
14,425
+8,000
+125% +$304K 0.21% 93
2021
Q2
$288K Buy
+6,425
New +$298K 0.21% 92

Other funds holding CELL

Summit Place Financial Advisors's CELL Position: Q3 2022 in Review

Summit Place Financial Advisors sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2022, closing a stake of 16,000 shares — an estimated $80K sold.

Summit Place Financial Advisors first reported a position in CELL in Q2 2021 and held it in 5 quarters. The position peaked at $288K in Q2 2021. 113 funds tracked by Wall St. Rank hold CELL as of Q3 2022.

  • Summit Place Financial Advisors reported no remaining PhenomeX Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Summit Place Financial Advisors sold 16,000 PhenomeX Inc. Common Stock shares in Q3 2022, an estimated $80K.
  • Summit Place Financial Advisors first reported a position in PhenomeX Inc. Common Stock in Q2 2021 and held it in 5 quarters.
  • Summit Place Financial Advisors's PhenomeX Inc. Common Stock position peaked at $288K in Q2 2021.
  • 113 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2022.

Based on Summit Place Financial Advisors's 13F filing for Q3 2022, filed 1 Nov 2022.